Silver Spring-based United Therapeutics settles patent dispute over Remodulin generic with Teva Pharmaceuticals - Washington Business Journal
Patent expiry dates for biologicals: 2017 update - GaBI Journal
Coreg: Glaxo Wins $235 Million Verdict Against Teva Over Patent Infringement - Bloomberg
Crowell & Moring Client Alert: NJ Federal Court Says Pharmaceutical Manufacturers Can Agree to Keep Generics Off The Market
TEVA drug pipeline, global patents
Truvada patent expires, potentially opening 'new doors' for PrEP access
3 Top Pharmaceuticals: Patents, Pipelines And Prospects | Seeking Alpha
List - 54 Drug Patents Expiring in 2024 - GreyB
Several blockbuster patents to expire in 2023 - BioStock
Top pharma companies by sales loss due to patent expirations until 2018 | Statista
US drug expiries: 2020 to be a big year for drug market exclusivity expiries
Top Drugs Losing Patent Protection in 2022 | Generic Drugs Entry in 2022
Patent expiry dates for biologicals: 2017 update - GaBI Journal
Does Drug Patent Evergreening Prevent Generic Entry? – DrugPatentWatch - Make Better Decisions
One, two, three, gone: Teva loses third patent on new Copaxone formula | Fierce Pharma
High-Court-Sides-Teva-Patent
/cloudfront-us-east-2.images.arcpublishing.com/reuters/4KMTYB5S2ZMHROIUF6RPOGNX4M.jpg "Teva takes $235 mln 'skinny label' dispute with GSK to U.S. Supreme Court | Reuters")
Teva takes $235 mln 'skinny label' dispute with GSK to U.S. Supreme Court | Reuters
Can new CEO Erez Vigodman inject life back into Teva? | World Finance
Teva Capitalizes On Patent Expiry To Launch First Perforomist Rival :: Generics Bulletin
Global Generic Drugs Market Report 2022: Rapid Patent Expiry of Branded Drugs Creates Opportunities
Patent expiry dates for biologicals: 2018 update - GaBI Journal
Time for a Turnaround at Teva Pharmaceuticals Industries Ltd? | The Motley Fool
List - 91 Drug Patents that are Expiring between 2020 to 2022 - GreyB
